Princeton based WIRB-Copernicus Group (WCG) has acquired Raleigh-based Clintrax Global which helps drug companies with the business aspects of clinical trials. Financial details of the transaction were not disclosed.
Founded by former biopharmaceutical and clinical research organization (CRO) attorneys, Clintrax provides outsourced services for negotiating clinical trial-related contracts and budgets between biopharmaceutical companies, CROs and investigator sites around the world. Clintrax Global also manages, executes, and tracks payments between these clinical trial participants.
Since its inception, Clintrax Global has accelerated hundreds of clinical trials conducted in more than 65 countries.
It employs more than 60 attorneys located around the world. Its operations headquarters will remain in Raleigh.
